Literature DB >> 2360829

Further characterization of borderline methicillin-resistant Staphylococcus aureus and analysis of penicillin-binding proteins.

M P Montanari1, E Tonin, F Biavasco, P E Varaldo.   

Abstract

Eighty-nine Staphylococcus aureus strains were grouped according to their susceptibility or resistance to methicillin and oxacillin. The role of beta-lactamase in borderline methicillin resistance was confirmed by tests with beta-lactamase inhibitors, particularly when salt-supplemented medium was used. A penicillin-binding protein assay indicated that borderline methicillin-resistant S. aureus strains do not produce PBP 2a.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2360829      PMCID： PMC171719          DOI： 10.1128/AAC.34.5.911

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  10 in total

1.  Penicillin-binding proteins and the intrinsic resistance to beta-lactams in gram-positive cocci.

Authors:  R Fontana
Journal:  J Antimicrob Chemother       Date:  1985-10       Impact factor: 5.790

2.  Regulation of penicillin-binding protein activity: description of a methicillin-inducible penicillin-binding protein in Staphylococcus aureus.

Authors:  L Rossi; E Tonin; Y R Cheng; R Fontana
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

3.  Low-affinity penicillin-binding protein associated with beta-lactam resistance in Staphylococcus aureus.

Authors:  B J Hartman; A Tomasz
Journal:  J Bacteriol       Date:  1984-05       Impact factor: 3.490

4.  The role of beta-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins.

Authors:  L K McDougal; C Thornsberry
Journal:  J Clin Microbiol       Date:  1986-05       Impact factor: 5.948

5.  Increased amounts of a novel penicillin-binding protein in a strain of methicillin-resistant Staphylococcus aureus exposed to nafcillin.

Authors:  H F Chambers; B J Hartman; A Tomasz
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

6.  Beta-lactam-specific resistant mutants of Staphylococcus aureus.

Authors:  E Tonin; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

7.  Identification, clinical distribution, and susceptibility to methicillin and 18 additional antibiotics of clinical Staphylococcus isolates: nationwide investigation in Italy.

Authors:  P E Varaldo; P Cipriani; A Focá; C Geraci; A Giordano; M A Madeddu; A Orsi; R Pompei; M Prenna; A Repetto
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

8.  Role of an altered penicillin-binding protein in methicillin- and cephem-resistant Staphylococcus aureus.

Authors:  Y Utsui; T Yokota
Journal:  Antimicrob Agents Chemother       Date:  1985-09       Impact factor: 5.191

9.  Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureus.

Authors:  B J Hartman; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

10.  Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus.

Authors:  H F Chambers; C J Hackbarth
Journal:  Antimicrob Agents Chemother       Date:  1987-12       Impact factor: 5.191
  10 in total
  19 in total

1.  Disk with high oxacillin content discriminates between methicillin-resistant and borderline methicillin-susceptible Staphylococcus aureus strains in disk diffusion assays using a low salt concentration.

Authors:  A C Petersson; C Kamme; H Miörner
Journal:  J Clin Microbiol       Date:  1999-06       Impact factor: 5.948

2.  Distribution of mecA among methicillin-resistant clinical staphylococcal strains isolated at hospitals in Naples, Italy.

Authors:  E Galdiero; G Liguori; M D'Isanto; N Damiano; L Sommese
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 3.  Consequences of the interaction of beta-lactam antibiotics with penicillin binding proteins from sensitive and resistant Staphylococcus aureus strains.

Authors:  H Labischinski
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

4.  Dutch guideline on the laboratory detection of methicillin-resistant Staphylococcus aureus.

Authors:  M F Q Kluytmans-van den Bergh; M C Vos; B M W Diederen; C M J E Vandenbroucke-Grauls; A Voss; J A J W Kluytmans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-27       Impact factor: 3.267

5.  Analysis of borderline oxacillin-resistant Staphylococcus aureus (BORSA) strains isolated in Tunisia.

Authors:  Senda Mezghani Maalej; Faouzia Mahjoubi Rhimi; Marguerite Fines; Basma Mnif; Roland Leclercq; Adnene Hammami
Journal:  J Clin Microbiol       Date:  2012-07-18       Impact factor: 5.948

6.  Diversity of methicillin-resistant Staphylococcus aureus isolated in a Canadian hospital.

Authors:  O Hammerberg; H Bialkowska-Hobrzanska; D Gregson; K McGhie; R Behme
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-03       Impact factor: 3.267

7.  Survey of clinical isolates of Staphylococcus aureus for borderline susceptibility to antistaphylococcal penicillins.

Authors:  P E Varaldo; M P Montanari; F Biavasco; E Manso; S Ripa; F Santacroce
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-09       Impact factor: 3.267

8.  Comparison of phenotypic methods and DNA hybridization for detection of methicillin-resistant Staphylococcus aureus.

Authors:  P Richard; M Meyran; E Carpentier; A Thabaut; H B Drugeon
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

9.  Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.

Authors:  L Hirano; A S Bayer
Journal:  Antimicrob Agents Chemother       Date:  1991-04       Impact factor: 5.191

10.  Detection of the Staphylococcal mecA gene by chemiluminescent DNA hybridization.

Authors:  C P Kolbert; J E Connolly; M J Lee; D H Persing
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.